What is the role of the EMA in orphan drugs for cancer?
Orphan drugs are medicines intended for the treatment of rare diseases, including rare types of cancer. The EMA provides incentives such as protocol assistance, reduced fees, and market exclusivity to encourage the development of orphan drugs. This support is crucial for addressing the unmet medical needs of patients with rare cancers.
